Tissue Total RNA, Cervix
$350.00
3 Days*
Product Data | |
Age | 49 |
---|---|
Appearance | Tumor |
Bioanalyzer Ratio (28S/18S) | 0.72 |
CASE Diagnosis (from medical center path report) | Adenocarcinoma of cervix, metastatic |
Case ID | CI0000007264 |
Diagnosis | Cervical Cancer |
Diagnostic Test Results | Cytokeratin 7 ~ CK7 ! by IHC,Positive, strong; Cytokeratin 20 ~ CK20 ! by IHC,Positive, weak |
Disease State | Cancer |
Gender | Female |
Lesional | 0% |
M (Distant metastasis) | M1 |
Minimum Stage Grouping | IV |
N (Lymph node metastasis) | N0 |
Necrosis | 1% |
Normal | 0% |
Prep | 1 |
Vial ID | RN00001240 |
Sample Diagnosis (from Pathology Verification) | Adenocarcinoma of cervix, metastatic |
Frozen Sample ID | FR0001EA4C |
Site of Finding | Ovary |
Stability | These products are stable for one year from date of shipping when stored at -80°C without repeated freeze/thaws. |
Storage | Store tissue total RNA at -80°C. |
T (Extent of Primary Tumor) | TX |
Tissue | Cervix |
Tissue of Origin | Cervix |
Tumor | 85% |
Tumor Grade | FIGO G2: Moderately differentiated |
Tumor Hypo/Acellular Stroma | 14% |
Tumor Hypercellular Stroma | 0% |
Shipping | Dry Ice |
Description | RNA (5 µg); Cervix; Adenocarcinoma of cervix, metastatic |
Write Your Own Review
Datasheet | |
SDS | |
Citations
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen
complexities in the preparation of your product. International customers may expect an additional 1-2 weeks
in shipping.